CRBP · TickerCove

CRBPCorbus Pharmaceuticals Holdings, Inc.Healthcare · Biotechnologyas of 2026-09-16

Horizon

Issued 2026-09-16 at $7.26 · now $7.26 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, CRBP has typically landed between $4.74 and $11.19 — a range of −34.7% to +54.1% from the issuance price $7.26.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

2,964 overlapping 1 month windows · 2014-10-27 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($7.26) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$7.26 · 3% of range

$6.92 low$19.36 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

−2.9%

typical move · IQR 33.9%

−34.7%worst (p90)+54.1%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where CRBP has typically landed a month from the 2026-09-16 close of $7.26 — the range is history, not a prediction.

now $7.26 (+0.0%)
typical $7.05 (-2.9%)
middle 50% $5.82–$8.28
90% range $4.74–$11.19

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 2,964 windows spanning 2014-10-27 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2020-09-03	−87.1%	−87.1%	+0.0%
2020-09-04	−86.9%	−86.9%	+0.0%
2020-08-26	−81.0%	−82.6%	+8.7%
3 best
2023-12-29	+360.1%	−1.8%	+360.1%
2023-12-27	+334.5%	+0.0%	+334.5%
2023-12-28	+330.0%	−3.7%	+330.0%

2,964 overlapping windows · 2014-10-27 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~12 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

58%

+30.8%

n=12

Feb

42%

−2.9%

n=12

Mar

67%

+19.2%

n=12

Apr

58%

+5.3%

n=12

May

58%

+5.6%

n=12

Jun

33%

−4.4%

n=12

Jul

25%

−5.0%

n=12

Aug

67%

+10.6%

n=12

Sep

25%

−10.7%

n=12

Oct

18%

−12.4%

n=11

Nov

67%

+12.0%

n=12

Dec

25%

−12.1%

n=12

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2026-09-14	Ben Yong	director	Sale	2,000 @ $7.84	$16K	−17.6% of holding	not yet — horizon still open	not yet — horizon still open	9,383	Form 4 · filed 1 day after the trade
2026-08-11	Saxena Nishant C	officer	Purchase	2,600 @ $9.63	$25K	+3.5% of holding	−11.7%	not yet — horizon still open	77,900	Form 4 · filed 1 day after the trade
2026-08-07	Cohen Yuval	director	Sale	17,000 @ $10.08	$171K	−9.8% of holding	+5.2%	not yet — horizon still open	157,316	Form 4 · filed 3 days after the trade
2026-08-07	Moran Sean F.	officer	Sale	12,000 @ $10.08	$121K	−12.4% of holding	+5.2%	not yet — horizon still open	84,694	Form 4 · filed 3 days after the trade
2026-06-10	Jenkins John Kenneth	director	Sale	4,800 @ $7.91	$38K	−55.6% of holding	+13.9%	not yet — horizon still open	3,833	Form 4 · filed 1 day after the trade
2026-06-10	Altmeyer Anne	director	Sale	2,412 @ $7.91	$19K	−24.1% of holding	+13.9%	not yet — horizon still open	7,579	Form 4 · filed 1 day after the trade
2026-06-10	Kung Winston	director	Sale	2,026 @ $7.91	$16K	−14.3% of holding	+13.9%	not yet — horizon still open	12,140	Form 4 · filed 1 day after the trade
2026-06-03	Saxena Nishant C	officer	Purchase	9,000 @ $7.58	$68K	+13.6% of holding	+22.1%	not yet — horizon still open	75,300	Form 4 · filed same day
2026-06-02	Saxena Nishant C	officer	Purchase	4,500 @ $7.33	$33K	+7.3% of holding	+24.4%	not yet — horizon still open	66,300	Form 4 · filed 1 day after the trade
2026-03-02	Smethurst Dominic	officer	Sale	6,097 @ $8.30	$51K	−6.4% of holding	+17.4%	+18.3%	89,790	Form 4 · filed 2 days after the trade
2026-02-17	Hodgson Ian	officer	Sale	847 @ $7.38	$6K	−1.6% of holding	+23.5%	+21.1%	51,080	Form 4 · filed 1 day after the trade
2026-02-13	Cohen Yuval	director	Sale	13,871 @ $7.78	$108K	−7.4% of holding	+29.0%	+24.8%	174,316	Form 4 · filed 5 days after the trade
2026-02-13	Moran Sean F.	officer	Sale	4,701 @ $7.78	$37K	−4.6% of holding	+29.0%	+24.8%	96,694	Form 4 · filed 5 days after the trade
2026-02-03	Smethurst Dominic	officer	Sale	3,285 @ $8.09	$27K	−3.3% of holding	+0.2%	+5.9%	95,887	Form 4 · filed 1 day after the trade
2026-02-03	Hodgson Ian	officer	Sale	2,415 @ $8.09	$20K	−4.4% of holding	+0.2%	+5.9%	51,927	Form 4 · filed 1 day after the trade
2025-12-11	Cormorant Asset Management, LP	other	Sale	30,029 @ $11.46	$344K	−1.3% of holding	−18.9%	−24.2%	2,344,971	Form 4 · filed 4 days after the trade
2025-10-27	Cohen Yuval	director	Sale	8,973 @ $17.14	$154K	−6.1% of holding	−31.7%	−46.7%	138,187	Form 4 · filed same day
2025-10-24	Cohen Yuval	director	Sale	18,660 @ $17.01	$317K	−11.9% of holding	−31.0%	−47.5%	138,187	Form 4 · filed 3 days after the trade
2025-10-24	Moran Sean F.	officer	Sale	12,981 @ $17.02	$221K	−15.0% of holding	−31.0%	−47.5%	73,313	Form 4 · filed 3 days after the trade
2025-10-20	Altmeyer Anne	director	Sale	1,060 @ $20.50	$22K	−14.6% of holding	−32.6%	−49.2%	6,191	Form 4 · filed 1 day after the trade
2025-05-30	Jenkins John Kenneth	director	Sale	2,783 @ $7.35	$20K	−98.8% of holding	−8.6%	+38.9%	33	Form 4 · filed 3 days after the trade
2025-05-30	Altmeyer Anne	director	Sale	1,392 @ $7.25	$10K	−50.0% of holding	−8.6%	+38.9%	1,391	Form 4 · filed 3 days after the trade
2025-03-06	Smethurst Dominic	officer	Sale	6,393 @ $6.78	$43K	−8.3% of holding	−16.5%	+27.8%	70,807	Form 4 · filed 1 day after the trade
2025-02-14	Cohen Yuval	director	Sale	7,134 @ $8.76	$62K	−4.9% of holding	−17.6%	+2.6%	138,187	Form 4 · filed 4 days after the trade
2025-02-14	Moran Sean F.	officer	Sale	2,792 @ $8.76	$24K	−3.7% of holding	−17.6%	+2.6%	73,313	Form 4 · filed 4 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

50 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-08-16	Nicacio Leonardo Viana	officer	Award / grant	191,676	191,676	Form 4
2026-08-16	Nicacio Leonardo Viana	officer	Award / grant	58,333	58,333	Form 4
2026-05-21	Saxena Nishant C	officer	Award / grant	58,300	61,800	Form 4
2026-05-21	Saxena Nishant C	officer	Award / grant	192,300	192,300	Form 4
2026-05-19	Kung Winston	director	Award / grant	3,800	14,166	Form 4
2026-05-19	Kung Winston	director	Award / grant	12,300	12,300	Form 4
2026-05-19	Jacques Rachelle Suzanne	director	Award / grant	12,300	12,300	Form 4
2026-05-19	Jenkins John Kenneth	director	Award / grant	3,800	8,633	Form 4
2026-05-19	Jenkins John Kenneth	director	Award / grant	12,300	12,300	Form 4
2026-05-19	Jacques Rachelle Suzanne	director	Award / grant	3,800	11,383	Form 4
2026-05-19	Altmeyer Anne	director	Award / grant	3,800	9,991	Form 4
2026-05-19	Altmeyer Anne	director	Award / grant	12,300	12,300	Form 4
2026-05-19	Pfeiffenberger Brent	director	Award / grant	7,500	7,500	Form 4
2026-05-19	Pfeiffenberger Brent	director	Award / grant	24,700	24,700	Form 4
2026-05-19	Ben Yong	director	Award / grant	3,800	11,383	Form 4
2026-05-19	Ben Yong	director	Award / grant	12,300	12,300	Form 4
2026-01-14	Moran Sean F.	officer	Award / grant	28,082	101,395	Form 4
2026-01-14	Moran Sean F.	officer	Award / grant	84,247	84,247	Form 4
2026-01-14	Hodgson Ian	officer	Award / grant	28,365	54,342	Form 4
2026-01-14	Hodgson Ian	officer	Award / grant	85,095	85,095	Form 4
2026-01-14	Smethurst Dominic	officer	Award / grant	28,365	99,172	Form 4
2026-01-14	Smethurst Dominic	officer	Award / grant	85,095	85,095	Form 4
2026-01-14	Cohen Yuval	director	Award / grant	50,000	188,187	Form 4
2026-01-14	Cohen Yuval	director	Award / grant	150,000	150,000	Form 4
2025-10-27	Cohen Yuval	director	Option exercise	8,973	147,160	Form 4
2025-10-27	Cohen Yuval	director	Option exercise	8,973	22,106	Form 4
2025-10-24	Cohen Yuval	director	Option exercise	18,660	156,847	Form 4
2025-10-24	Moran Sean F.	officer	Option exercise	12,981	86,294	Form 4
2025-10-24	Moran Sean F.	officer	Option exercise	12,981	10,386	Form 4
2025-10-24	Cohen Yuval	director	Option exercise	18,660	31,079	Form 4
2025-10-20	Altmeyer Anne	director	Option exercise	1,060	7,251	Form 4
2025-10-20	Altmeyer Anne	director	Option exercise	1,060	4,247	Form 4
2025-05-30	Altmeyer Anne	director	Award / grant	4,800	6,191	Form 4
2025-05-30	Jacques Rachelle Suzanne	director	Award / grant	16,000	16,000	Form 4
2025-05-30	Altmeyer Anne	director	Award / grant	16,000	16,000	Form 4
2025-05-30	Jenkins John Kenneth	director	Award / grant	4,800	4,833	Form 4
2025-05-30	Jenkins John Kenneth	director	Award / grant	16,000	16,000	Form 4
2025-05-30	Kung Winston	director	Award / grant	4,800	10,366	Form 4
2025-05-30	Kung Winston	director	Award / grant	16,000	16,000	Form 4
2025-05-30	Ben Yong	director	Award / grant	16,000	16,000	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

27d remaining

2026-09-174% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i